Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Allergy and Clinical Immunology Année : 2017

Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes

Résumé

The outcome of bullous pemphigoid (BP), the most frequent autoimmune skin-blistering disease, involves matrix metalloproteinase 9 (MMP-9), IL-17, and IL-23 release from infiltrated inflammatory cells. The chemokine CXCL10 has been associated with several autoimmune diseases, but its participation in BP pathophysiology still needs to be clarified.

Dates et versions

hal-01754072 , version 1 (30-03-2018)

Identifiants

Citer

Meriem Riani, Sébastien Le Jan, Julie Plée, Anne Durlach, Richard Le Naour, et al.. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. Journal of Allergy and Clinical Immunology, 2017, 139 (3), pp.863 - 872.e3. ⟨10.1016/j.jaci.2016.08.012⟩. ⟨hal-01754072⟩
89 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More